BackRecce Pharmaceuticals Overview

Recce Pharmaceuticals Total Assets

Track Recce Pharmaceuticals's total assets ($8.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$8.53M
↓ 31.31% YoYΔ $-3.89M vs prior year quarter

Peer trimmed avg / median

Loading

Recce Pharmaceuticals Total Assets History

Loading

Recce Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Recce Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Recce Pharmaceuticals (RECEF) FAQ

As of the most recent data (June 2026), RECEF shows a total assets of $8.5M. That compares with $12M in the prior-year period — down 31.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RECEF's total assets is now $8.5M (was $12M) — a 31.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Recce Pharmaceuticals is outperforming or lagging.

Tracking RECEF's total assets over time shows whether Recce Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $8.5M That compares with $12M in the prior-year period — down 31.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Recce Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $8.5M) with ownership activity and broader fundamentals.

Recce Pharmaceuticals's total assets is $8.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.